TE_163
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSp |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | ESPNP, ENSG00000293526 |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 3.73 |
| Counts of samples | TCGA_tumor:52; TCGA_normal:1; GTEx:14 |
| TSS | chr1(-):16717356 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_163.1 | ESPNP, ENSG00000293526 | Chimeric | Other | MTPLHAAAQMGHSPVIVWLVSCTDVSLSEQDKDGATATHFAASRGHSKVLSWLLLHGGEISADLWGGTALYDAAENGELECCQILVVNGAELEVRDRDGYAAADLSDFNGHSHCTHCLRTVENLSMEHCVLSRDPSVELEAKQPDSGMSSPNTTVSVQPLNFDLSSPTSTLSNYDSCSSSHSSIKGQHPPRGLSSTRAADIQSYMDMLNPELGLPWGTIGKPIPPPPPPSFPPPPPPPGTQLPPPPPSYPSPKPPVGPQAADIYMQTKNKLRHVETEALKKEPSSCDGHDGLRRQDSSRKPRAFSKQPSTGDYYRQLGRCPGETLVARPGMAHREEAELPGNHVPNGCAADPKASREQQLPPPPPPPPLPEAASSPPPVPPLPLEGAGPGCGQRRSSSPTGSTKSFNVMFPMGDNSELLAEIKAGKSLKPTPQSKGLTTVFSGSRQPAFQPDWPLPSVSPALLPVRSPTPPAAGFQPLLNGSLVPVPPTTPAPGVQLDVEALIPTHDEQGRPKPEWKRQVMVGKMQLKMEEEEEQRWKYPREGWRYSREHNAILWPFGELMTEADILRIEQQSRTCRCCTRRRSWRRAWSNWS* | chr1(-):16691274,16691294,16692280,16694034,16696431,16696694,16696779,16696924,16699426,16699621,16699859,16700020,16702701,16702972,16703943,16704144,16707288,16707419,16707545,16707727,16707892,16708078,16717260,16717357 |
| teRNA_163.2 | ESPNP, ENSG00000293526 | Chimeric | Non-coding | Non-coding | chr1(-):16707707,16707727,16707892,16708078,16717260,16717357 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
